GB201912411D0 - Crystalline forms of ivosidenib - Google Patents

Crystalline forms of ivosidenib

Info

Publication number
GB201912411D0
GB201912411D0 GBGB1912411.4A GB201912411A GB201912411D0 GB 201912411 D0 GB201912411 D0 GB 201912411D0 GB 201912411 A GB201912411 A GB 201912411A GB 201912411 D0 GB201912411 D0 GB 201912411D0
Authority
GB
United Kingdom
Prior art keywords
ivosidenib
crystalline forms
crystalline
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1912411.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson Matthey PLC
Original Assignee
Johnson Matthey PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey PLC filed Critical Johnson Matthey PLC
Priority to GBGB1912411.4A priority Critical patent/GB201912411D0/en
Publication of GB201912411D0 publication Critical patent/GB201912411D0/en
Priority to PCT/GB2020/052016 priority patent/WO2021038204A1/en
Ceased legal-status Critical Current

Links

GBGB1912411.4A 2019-08-29 2019-08-29 Crystalline forms of ivosidenib Ceased GB201912411D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1912411.4A GB201912411D0 (en) 2019-08-29 2019-08-29 Crystalline forms of ivosidenib
PCT/GB2020/052016 WO2021038204A1 (en) 2019-08-29 2020-08-21 Crystalline forms of ivosidenib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1912411.4A GB201912411D0 (en) 2019-08-29 2019-08-29 Crystalline forms of ivosidenib

Publications (1)

Publication Number Publication Date
GB201912411D0 true GB201912411D0 (en) 2019-10-16

Family

ID=68207040

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1912411.4A Ceased GB201912411D0 (en) 2019-08-29 2019-08-29 Crystalline forms of ivosidenib

Country Status (2)

Country Link
GB (1) GB201912411D0 (en)
WO (1) WO2021038204A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11066390B2 (en) * 2017-11-27 2021-07-20 Assia Chemical Industries Ltd. Solid state forms of Ivosidenib

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ723859A (en) * 2014-03-14 2023-01-27 Servier Lab Pharmaceutical compositions of therapeutically active compounds and their uses
EP3362066B1 (en) * 2015-10-15 2021-10-06 Les Laboratoires Servier SAS Combination therapy for treating malignancies
US11066390B2 (en) * 2017-11-27 2021-07-20 Assia Chemical Industries Ltd. Solid state forms of Ivosidenib
MA53099A (en) * 2018-07-06 2021-05-12 Agios Pharmaceuticals Inc IVOSIDENIB FORMS AND PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
WO2021038204A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
IL276644A (en) Novel crystalline forms
IL268852A (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
IL286218A (en) Solid state forms of ripretinib
EP3684358A4 (en) New crystalline polymorph of ponesimod
SI3380554T1 (en) Crystalline forms of per-chloro-gamma-cyclodextrines
HK1244274A1 (en) Crystalline forms of c21h22ci2n4o2
PL3532457T3 (en) Crystalline forms of hydroxynorketamine
EP3897660A4 (en) Novel crystalline forms of an nrtti compound
IL253479A0 (en) Crystalline forms of efinaconazole
SI3749673T1 (en) Crystalline form of bictegravir sodium
IL285219A (en) Crystal of diarylthiohydantoin compound
IL270961A (en) Crystalline form of n-butyldeoxygalactonojirimycin
IL269792B (en) Crystalline forms of (s)-afoxolaner
EP3793980A4 (en) Crystalline form of s-apomorphine
IL269073A (en) Crystalline forms of obeticholic acid
GB201912411D0 (en) Crystalline forms of ivosidenib
SG11202108905UA (en) Crystalline form of an avibactam derivative
ZA202105399B (en) Use of spiropidion
IL276107A (en) Solid forms of fasoracetam
IL278054A (en) The crystalline forms of a compound
GB201915908D0 (en) Crystalline forms of entrectinib
EP3687987A4 (en) Crystalline forms of lenalidomide
GB201911797D0 (en) Crystalline forms
IL270937A (en) Crystalline forms of seletalisib
GB202009218D0 (en) Crystalline forms of entrectinib

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)